Antibody fragments pose unique challenges in terms of recovery, purification, and formulation.
Mark Wagner
Advertisement
Mark Wagner is purification technology and business development specialist at EMD Millipore, 290 Concord Road, Billerica, MA 01821.
Articles by Mark Wagner
Advertisement
Latest Updated Articles
Challenges and Strategies for the Downstream Purification and Formulation of Fab Antibody FragmentsPublished: January 2nd 2014 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
3
Challenges for the Global Manufacturing of Vaccines
4
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
5
